EliquisTablets 5mg recall: Labeling Error
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017…
Why was EliquisTablets 5mg recalled?
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: HN0063, EXP. 09/2019
- Product
- EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017…
- Recalling firm
- Bristol-myers Squibb Company
- Quantity
- 48,180 bottles
- Distribution
- Nationwide in the US
- Recall date
- July 19, 2017
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)